マイクロカテーテル市場:タイプ(デリバリー、診断、吸引、ステアラブル)、デザイン(シングル、デュアル)、アプリケーション(心臓血管、神経血管、末梢血管、腫瘍)、エンドユーザー(病院、外来外科センター)別 - 2027年までの世界予測Microcatheter Market by Type (Delivery, Diagnostic, Aspiration, Steerable), Design (Single, Dual), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology), End-User (Hospital and Ambulatory Surgical Centers) - Global Forecasts to 2027 マイクロカテーテルの世界市場は、2022年の8億2800万米ドルから2027年には10億8200万米ドルに達すると予測され、予測期間中のCAGRは5.5%となります。低侵襲手術の採用拡大、高齢者の増加、心血管・神経血管疾患の... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーマイクロカテーテルの世界市場は、2022年の8億2800万米ドルから2027年には10億8200万米ドルに達すると予測され、予測期間中のCAGRは5.5%となります。低侵襲手術の採用拡大、高齢者の増加、心血管・神経血管疾患の有病率上昇、座りがちなライフスタイルや食習慣の増加などの要因により、心停止の症例が増加しており、病院での低侵襲手術が増加しています。"デリバリーマイクロカテーテルが2022年に市場最大のシェアを占める" デリバリーマイクロカテーテルは、2022年に最大の市場シェアを占めます。このセグメントの大きなシェアは、マイクロカテーテルの使い方を適切に理解していることと、開腹手術に代わる非外科的処置が増加していることに起因しています。 "診療所、病院、医療スパセグメントは、予測期間中に最高のCAGRを記録すると予測されている" エンドユーザーに基づいて、マイクロカテーテル市場は、病院、外科センター、および専門クリニックに区分されます。病院、外科センター、専門クリニックは、2022年から2027年の予測期間中に最も高いCAGRを記録すると予測されています。このセグメントの成長を支える主な要因は、病院における高品質の非外科用機器と人材の利用可能性、病院環境で行われる低侵襲処置に関する意識の高まり、形成外科医の数の増加である。 "予測期間中、北米地域の市場が最も高い成長を遂げると予想される。" 北米は2022年に最大の市場シェア-46.4%を占めました。このシェアは、関連する疾患や障害の高い有病率と相まって、この地域で行われる多くの対象処置(特に心臓血管、神経血管、腫瘍を含む)に起因するものであると考えられる。また、米国には確立された医療制度があり、病院が手術能力の向上と拡大のために投資を続けていることも、北米のマイクロカテーテル市場の成長を促進すると予想される要因の1つとなっています。 米国と欧州のマイクロカテーテル市場は、市場の飽和により成長が停滞していますが、APACの市場は今後数年間で大きな成長を遂げると予想されています。APAC地域のマイクロカテーテル市場は、予測期間中にCAGR 6.9%を記録する見込みです。これは主に、アジア諸国における病院数の増加、政府の有利な取り組み、ヘルスケア産業の成長、対象疾患・障害の有病率の上昇などが要因です。 本レポートで参照した主な参加企業の内訳は以下のとおりです。 - 企業タイプ別企業タイプ別:Tier 1-30%, Tier 2-42%, Tier 3- 28 - 役職別役職別:Cレベル-10%、ディレクターレベル-76%、その他-14 - 地域別地域別:北米-40%、欧州-30%、アジア太平洋-22%、中南米-6%、中東・アフリカ-2 マイクロカテーテル市場の有力企業 Boston Scientific Corporation.(米国)、Stryker Corporation(米国)、Teleflex Incorporated(米国)、Cook Group(米国)、Becton Dickinson and Company(米国)、朝日インテック株式会社(日本)などが挙げられます。 調査対象 本レポートでは、マイクロカテーテル市場を製品、製品設計、エンドユーザー、地域に基づいて調査しています。また、市場成長に影響を与える要因を取り上げ、市場における様々な機会や課題を分析し、市場リーダー向けの競争環境の詳細を提供します。さらに、個々の成長動向に関してマイクロマーケットを分析し、主要5地域(およびこれらの地域のそれぞれの国)に関して市場セグメントの収益を予測します。 本レポートを購入する理由 本レポートは、既存企業や新規参入企業/小規模企業が市場の動向を把握するのに役立ち、ひいてはより大きな市場シェアを獲得するのに役立つことでしょう。本レポートを購入された企業は、以下の戦略の1つまたは複数を組み合わせて、市場での存在感を高めることができます。 本レポートでは、以下のポイントについて考察しています。 - 市場浸透。マイクロカテーテル市場のトッププレイヤーが提供する製品ポートフォリオに関する包括的な情報。 - 製品開発/イノベーション。マイクロカテーテル市場における今後の動向、R&D活動、製品発表に関する詳細な洞察。 - 市場開発。有利な新興地域に関する包括的な情報 - 市場の多様化。新製品、成長地域、マイクロカテーテル市場の最新動向に関する徹底的な情報。 - 競争力のある評価。市場セグメント、成長戦略、収益分析、主要な市場プレイヤーの製品に関する詳細な評価。 目次1 INTRODUCTION 241.1 STUDY OBJECTIVES 24 1.2 MARKET DEFINITION 24 1.2.1 INCLUSIONS AND EXCLUSIONS 24 1.3 MARKET SCOPE 25 1.3.1 MARKETS COVERED 25 FIGURE 1 MICROCATHETERS MARKET, BY SEGMENTATION 25 FIGURE 2 MICROCATHETERS MARKET, BY REGION 25 1.3.2 YEARS CONSIDERED 26 1.4 CURRENCY CONSIDERED 26 1.5 STAKEHOLDERS 26 1.6 SUMMARY OF CHANGES 27 2 RESEARCH METHODOLOGY 28 2.1 RESEARCH DATA 28 2.2 RESEARCH DESIGN 28 FIGURE 3 MICROCATHETERS MARKET: RESEARCH DESIGN 28 2.2.1 SECONDARY DATA 29 2.2.2 PRIMARY DATA 29 FIGURE 4 PRIMARY SOURCES 29 2.2.2.1 Key data from primary sources 30 2.2.2.2 Insights from primary experts 30 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 31 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 31 2.3 MARKET SIZE ESTIMATION 31 FIGURE 7 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 32 FIGURE 8 TOP-DOWN APPROACH 33 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 35 FIGURE 9 DATA TRIANGULATION METHODOLOGY 35 2.5 MARKET SHARE ESTIMATION 35 2.6 RESEARCH ASSUMPTIONS 36 2.7 STUDY LIMITATIONS 36 2.7.1 METHODOLOGY-RELATED LIMITATIONS 36 2.8 RISK ASSESSMENT 36 TABLE 1 LIMITATIONS AND ASSOCIATED RISKS 36 3 EXECUTIVE SUMMARY 37 FIGURE 10 MICROCATHETERS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 37 FIGURE 11 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2022 VS. 2027 (USD MILLION) 38 FIGURE 12 MICROCATHETERS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 38 FIGURE 13 MICROCATHETERS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 39 FIGURE 14 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 39 4 PREMIUM INSIGHTS 41 4.1 MICROCATHETERS MARKET OVERVIEW 41 FIGURE 15 TECHNOLOGICAL ADVANCEMENTS AND RISING CHRONIC DISEASE INCIDENCE TO DRIVE DEMAND 41 4.2 MICROCATHETERS MARKET SHARE, BY COUNTRY AND PRODUCT 42 FIGURE 16 NORTH AMERICA TO HOLD LARGEST SHARE OF GLOBAL MARKET 42 4.3 MICROCATHETERS MARKET SHARE, BY END USER 42 FIGURE 17 HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 42 4.4 GEOGRAPHICAL SNAPSHOT OF MICROCATHETERS MARKET 43 FIGURE 18 INDIA TO GROW AT HIGHEST RATE DURING 2022–2027 43 5 MARKET OVERVIEW 44 5.1 INTRODUCTION 44 5.2 MARKET DYNAMICS 44 FIGURE 19 MICROCATHETERS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 44 5.2.1 DRIVERS 45 5.2.1.1 Technological advancements in interventional cardiology 45 5.2.1.2 Expansion of patient population suffering from chronic illness 45 5.2.1.3 Increasing conferences and symposia to spread awareness about benefits of microcatheters 45 5.2.2 RESTRAINTS 46 5.2.2.1 Stringent regulatory guidelines and high cost of drug approval 46 5.2.2.2 Lack of awareness about microcatheters in underdeveloped or emerging countries 46 5.2.3 OPPORTUNITIES 46 5.2.3.1 Rising number of patients suffering from chronic diseases and cancer globally 46 5.3 KEY STAKEHOLDERS AND BUYING CRITERIA 47 5.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 47 FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROCATHETERS MARKET 47 TABLE 2 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR MICROCATHETERS MARKET 47 5.4 PORTER’S FIVE FORCES ANALYSIS 47 5.4.1 OVERVIEW 47 TABLE 3 MICROCATHETERS MARKET: PORTER’S FIVE FORCES ANALYSIS 48 5.4.2 THREAT OF NEW ENTRANTS 48 5.4.3 THREAT OF SUBSTITUTES 48 5.4.4 BARGAINING POWER OF SUPPLIERS 48 5.4.5 BARGAINING POWER OF BUYERS 48 5.4.6 DEGREE OF COMPETITION 49 5.5 REGULATORY ANALYSIS 49 5.5.1 US 49 TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 50 5.5.2 EUROPE 50 5.5.3 JAPAN 50 TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 51 5.6 REIMBURSEMENT ANALYSIS 51 TABLE 6 CPT CODES FOR MAJOR MICROCATHETERS 51 5.7 ECOSYSTEM ANALYSIS 52 5.8 VALUE CHAIN ANALYSIS 53 5.8.1 RESEARCH AND DEVELOPMENT 53 5.8.2 PROCUREMENT AND PRODUCT DEVELOPMENT 53 5.8.3 MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES 53 FIGURE 21 VALUE CHAIN ANALYSIS 53 5.9 SUPPLY CHAIN ANALYSIS 54 5.9.1 PROMINENT COMPANIES 54 5.9.2 SMALL & MEDIUM-SIZED COMPANIES 54 5.9.3 END USERS 54 FIGURE 22 SUPPLY CHAIN ANALYSIS 54 5.10 PATENT ANALYSIS 54 5.11 TRADE ANALYSIS 55 TABLE 7 IMPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2020–2022 (USD MILLION) 55 TABLE 8 EXPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2020–2022 (USD MILLION) 55 5.12 KEY CONFERENCES AND EVENTS IN 2022–2023 56 TABLE 9 MICROCATHETERS MARKET: DETAILED LIST OF MAJOR CONFERENCES AND EVENTS 56 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 56 FIGURE 23 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX 57 6 MICROCATHETER MARKET, BY PRODUCT 58 6.1 INTRODUCTION 59 TABLE 10 MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 59 TABLE 11 MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 59 TABLE 12 MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 60 TABLE 13 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 60 6.2 DELIVERY MICROCATHETERS 60 6.2.1 INCREASED NUMBER OF TARGET INTERVENTIONAL PROCEDURES TO DRIVE MARKET 60 TABLE 14 DELIVERY MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 61 TABLE 15 DELIVERY MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 61 TABLE 16 DELIVERY MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 62 TABLE 17 DELIVERY MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 62 6.3 ASPIRATION MICROCATHETERS 63 6.3.1 INCREASING BURDEN OF CARDIOVASCULAR DISEASES AND RELATED MEDICAL PROCEDURES TO AUGMENT MARKET 63 TABLE 18 ASPIRATION MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 63 TABLE 19 ASPIRATION MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 63 TABLE 20 ASPIRATION MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 64 TABLE 21 ASPIRATION MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 64 6.4 DIAGNOSTICS MICROCATHETERS 65 6.4.1 LARGE PATIENT POPULATION FOR VASCULAR DISEASES TO AID MARKET 65 TABLE 22 DIAGNOSTIC MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 65 TABLE 23 DIAGNOSTIC MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 65 TABLE 24 DIAGNOSTIC MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 66 TABLE 25 DIAGNOSTIC MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 66 6.5 STEERABLE MICROCATHETERS 67 6.5.1 GROWING NUMBER OF IMAGE-GUIDED AND MINIMALLY INVASIVE MEDICAL PROCEDURES TO BOOST MARKET 67 TABLE 26 STEERABLE MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 67 TABLE 27 STEERABLE MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 67 TABLE 28 STEERABLE MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 68 TABLE 29 STEERABLE MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 68 7 MICROCATHETERS MARKET, BY PRODUCT DESIGN 69 7.1 INTRODUCTION 70 TABLE 30 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 70 7.2 SINGLE LUMEN MICROCATHETERS 70 7.2.1 INCREASING NUMBER OF TARGET MEDICAL PROCEDURES AND OPERATIONAL ADVANTAGES TO PROPEL MARKET 70 TABLE 31 SINGLE LUMEN MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 71 7.3 DUAL-LUMEN MICROCATHETERS 71 7.3.1 PRODUCT ADVANTAGES AND INCREASED ADOPTION OF CATHETERS TO DRIVE MARKET 71 TABLE 32 DUAL-LUMEN MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 72 8 MICROCATHETERS MARKET, BY APPLICATION 73 8.1 INTRODUCTION 74 TABLE 33 MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 74 8.2 CARDIOVASCULAR APPLICATIONS 74 8.2.1 PROCEDURAL BENEFITS DURING CRITICAL CARDIAC SURGERIES TO AID MARKET 74 TABLE 34 MICROCATHETERS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 75 8.3 NEUROVASCULAR APPLICATIONS 75 8.3.1 INCREASING INCIDENCE OF TARGET NEUROLOGICAL CONDITIONS TO DRIVE MARKET 75 TABLE 35 MICROCATHETERS MARKET FOR NEUROVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 76 8.4 PERIPHERAL VASCULAR APPLICATION 76 8.4.1 RISING TARGET DIAGNOSTIC AND INTERVENTIONAL PROCEDURES TO STIMULATE MARKET 76 TABLE 36 MICROCATHETERS MARKET FOR PERIPHERAL VASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 77 8.5 ONCOLOGY APPLICATIONS 77 8.5.1 INCREASING CLINICAL RESEARCH ON MINIMALLY INVASIVE CANCER TREATMENT TO DRIVE MARKET 77 TABLE 37 MICROCATHETERS MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 78 9 MICROCATHETERS MARKET, BY END USER 79 9.1 INTRODUCTION 80 TABLE 38 MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 80 9.2 HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS 80 9.2.1 LARGE NUMBER OF SURGICAL AND DIAGNOSTIC PROCEDURES TO PROPEL MARKET 80 TABLE 39 MICROCATHETERS MARKET FOR HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS, BY REGION, 2020–2027 (USD MILLION) 81 9.3 AMBULATORY CARE CENTERS 81 9.3.1 LIMITED SURGICAL CAPABILITIES OF AVAILABLE PRODUCTS TO RESTRAIN ADOPTION 81 TABLE 40 MICROCATHETERS MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2020–2027 (USD MILLION) 82 10 MICROCATHETERS MARKET, BY REGION 83 10.1 INTRODUCTION 84 TABLE 41 MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 84 10.2 NORTH AMERICA 85 FIGURE 24 NORTH AMERICA: MARKET SNAPSHOT 85 TABLE 42 NORTH AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85 TABLE 43 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 86 TABLE 44 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 86 TABLE 45 NORTH AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 87 TABLE 46 NORTH AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 87 10.2.1 US 88 10.2.1.1 US to dominate North American market during forecast period 88 TABLE 47 US: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 88 10.2.2 CANADA 88 10.2.2.1 Increasing prevalence of target diseases and high demand for timely diagnosis to propel market 88 TABLE 48 CANADA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 89 10.3 EUROPE 89 TABLE 49 EUROPE: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89 TABLE 50 EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 90 TABLE 51 EUROPE: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 90 TABLE 52 EUROPE: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 90 TABLE 53 EUROPE: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 91 10.3.1 GERMANY 91 10.3.1.1 Increasing aging population and rising life expectancy to boost market 91 TABLE 54 GERMANY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 91 10.3.2 FRANCE 92 10.3.2.1 Significant evolution of healthcare sector to drive market 92 TABLE 55 FRANCE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 92 10.3.3 UK 92 10.3.3.1 High burden of chronic diseases and large volume of surgeries to augment market 92 TABLE 56 UK: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 93 10.3.4 ITALY 93 10.3.4.1 Increasing geriatric population to aid growth 93 TABLE 57 ITALY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 93 10.3.5 SPAIN 93 10.3.5.1 Increasing technological developments in healthcare sector to propel market 93 TABLE 58 SPAIN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 94 10.3.6 REST OF EUROPE 94 TABLE 59 REST OF EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 94 10.4 ASIA PACIFIC 95 FIGURE 25 ASIA PACIFIC: MARKET SNAPSHOT 95 TABLE 60 ASIA PACIFIC: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96 TABLE 61 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 96 TABLE 62 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 96 TABLE 63 ASIA PACIFIC: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 97 TABLE 64 ASIA PACIFIC: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 97 10.4.1 JAPAN 98 10.4.1.1 Increasing geriatric population and surgical procedures to drive market 98 TABLE 65 JAPAN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 98 10.4.2 CHINA 99 10.4.2.1 Growing prevalence of chronic disorders and developing healthcare infrastructure to aid growth 99 TABLE 66 CHINA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 99 10.4.3 INDIA 100 10.4.3.1 Increasing target patient population with rising availability of advanced surgical treatments to drive market 100 TABLE 67 INDIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 100 10.4.4 AUSTRALIA 100 10.4.4.1 Developing healthcare sector and increasing availability of advanced surgical treatments to stimulate market 100 TABLE 68 AUSTRALIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 101 10.4.5 SOUTH KOREA 101 10.4.5.1 Growing target patient population for cardiovascular diseases to drive market 101 TABLE 69 SOUTH KOREA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 101 10.4.6 REST OF ASIA PACIFIC 102 TABLE 70 REST OF ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 102 10.5 LATIN AMERICA 102 10.5.1 FAVORABLE ECOSYSTEM FOR MEDICAL EQUIPMENT AND SUPPLIES TO DRIVE MARKET 102 TABLE 71 LATIN AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 103 TABLE 72 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 103 TABLE 73 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 103 TABLE 74 LATIN AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 104 TABLE 75 LATIN AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 104 10.6 MIDDLE EAST & AFRICA 105 10.6.1 INCREASING FOCUS OF MARKET PLAYERS TO ESTABLISH THEIR PRESENCE TO PROPEL MARKET 105 TABLE 76 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 105 TABLE 77 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 106 TABLE 78 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 106 TABLE 79 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 106 11 COMPETITIVE LANDSCAPE 107 11.1 OVERVIEW 107 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 107 FIGURE 26 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MICROCATHETERS MARKET 108 11.3 MARKET RANKING ANALYSIS 109 FIGURE 27 MICROCATHETERS MARKET (2021) 109 11.3.1 BOSTON SCIENTIFIC CORPORATION 109 11.3.2 ASAHI INTECC CO., LTD. 110 11.3.3 MEDTRONIC PLC 110 11.3.4 TELEFLEX 110 11.3.5 TERUMO MEDICAL CORPORATION 111 11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 111 FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN MICROCATHETERS MARKET 111 11.5 COMPETITIVE BENCHMARKING OF TOP 26 PLAYERS 112 TABLE 80 OVERALL FOOTPRINT OF COMPANIES 112 TABLE 81 PRODUCT FOOTPRINT OF COMPANIES (26 COMPANIES) 113 TABLE 82 END USER FOOTPRINT OF COMPANIES (26 COMPANIES) 114 TABLE 83 REGIONAL FOOTPRINT OF COMPANIES (26 COMPANIES) 115 11.6 COMPANY EVALUATION QUADRANT 116 11.6.1 STARS 117 11.6.2 EMERGING LEADERS 117 11.6.3 PERVASIVE PLAYERS 117 11.6.4 PARTICIPANTS 117 FIGURE 29 MICROCATHETERS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021) 118 11.7 START-UPS/SMES EVALUATION QUADRANT 118 11.7.1 PROGRESSIVE COMPANIES 118 11.7.2 DYNAMIC COMPANIES 118 11.7.3 STARTING BLOCKS 119 11.7.4 RESPONSIVE COMPANIES 119 FIGURE 30 MICROCATHETERS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2021) 119 11.8 COMPETITIVE SCENARIO 120 11.8.1 PRODUCT LAUNCHES AND APPROVALS 120 TABLE 84 PRODUCT LAUNCHES AND APPROVALS, 2019–2022 120 11.8.2 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 121 TABLE 85 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2019–2022 121 12 COMPANY PROFILES 122 (Business Overview, Products/Services/Solutions offered, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats)* 12.1 KEY PLAYERS 122 12.1.1 BOSTON SCIENTIFIC CORPORATION 122 TABLE 86 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 122 FIGURE 31 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2021) 123 12.1.2 ASAHI INTECC CO., LTD. 125 TABLE 87 ASAHI INTECC CO., LTD: COMPANY OVERVIEW 125 FIGURE 32 ASAHI INTECC CO., LTD.: COMPANY SNAPSHOT (2021) 125 12.1.3 MEDTRONIC PLC 127 TABLE 88 MEDTRONIC PLC: COMPANY OVERVIEW 127 FIGURE 33 MEDTRONIC PLC.: COMPANY SNAPSHOT (2021) 128 12.1.4 STRYKER 130 TABLE 89 STRYKER: COMPANY OVERVIEW 130 FIGURE 34 STRYKER: COMPANY SNAPSHOT (2021) 131 12.1.5 BECTON, DICKINSON AND COMPANY 133 TABLE 90 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 133 FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021) 134 12.1.6 TERUMO MEDICAL CORPORATION 136 TABLE 91 TERUMO MEDICAL CORPORATION: COMPANY OVERVIEW 136 FIGURE 36 TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT (2021) 137 12.1.7 MERIT MEDICAL SYSTEMS, INC. 139 TABLE 92 MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW 139 FIGURE 37 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2021) 140 12.1.8 CARDINAL HEALTH 142 TABLE 93 CARDINAL HEALTH: COMPANY OVERVIEW 142 FIGURE 38 CARDINAL HEALTH: COMPANY SNAPSHOT (2021) 143 12.1.9 B. BRAUN MELSUNGEN AG 145 TABLE 94 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 145 12.1.10 COOK MEDICAL GROUP 147 TABLE 95 COOK MEDICAL GROUP: COMPANY OVERVIEW 147 12.1.11 TELEFLEX 150 TABLE 96 TELEFLEX: COMPANY OVERVIEW 150 12.1.12 JOHNSON & JOHNSON 151 TABLE 97 JOHNSON & JOHNSON: COMPANY OVERVIEW 151 12.1.13 ANGIODYNAMICS 152 TABLE 98 ANGIODYNAMICS: COMPANY OVERVIEW 152 12.1.14 PENUMBRA 153 TABLE 99 PENUMBRA: COMPANY OVERVIEW 153 12.1.15 BTG PLC 154 TABLE 100 BTG PLC: COMPANY OVERVIEW 154 12.1.16 GUERBET LLC 155 TABLE 101 GUERBET LLC: COMPANY OVERVIEW 155 12.1.17 EMBOLX INC. 156 TABLE 102 EMBOLX INC.: COMPANY OVERVIEW 156 12.1.18 TOKAI MEDICAL 157 TABLE 103 TOKAI MEDICAL: COMPANY OVERVIEW 157 12.1.19 KANEKA CORPORATION 158 TABLE 104 KANEKA CORPORATION.: COMPANY SNAPSHOT 158 12.1.20 INTEGER HOLDINGS CORPORATION 159 TABLE 105 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW 159 12.1.21 LIBATAPE PHARMACEUTICAL CO., LTD. 159 TABLE 106 LIBATAPE PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW 159 12.1.22 MICROVENTION TERUMO 160 TABLE 107 MICROVENTION TERUMO: COMPANY OVERVIEW 160 12.1.23 REFLOW MEDICAL 160 TABLE 108 REFLOW MEDICAL: COMPANY OVERVIEW 160 12.1.24 SPARTAN MICRO 161 TABLE 109 SPARTAN MICRO: COMPANY OVERVIEW 161 12.1.25 TRANSIT SCIENTIFIC 161 TABLE 110 TRANSIT SCIENTIFIC: COMPANY OVERVIEW 161 12.1.26 TRISALUS LIFE SCIENCES, INC. 162 TABLE 111 TRISALUS LIFE SCIENCES, INC.: COMPANY OVERVIEW 162 *Details on Business Overview, Products Offered, Recent Developments, Deals, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats might not be captured in case of unlisted companies. 13 APPENDIX 163 13.1 DISCUSSION GUIDE 163 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 166 13.3 CUSTOMIZATION OPTIONS 168 13.4 RELATED REPORTS 168 13.5 AUTHOR DETAILS 169
SummaryThe global microcatheter market is projected to reach USD 1,082 million by 2027 from USD 828 million in 2022, at a CAGR of 5.5% during the forecast period. Factors such as the growing adoption of minimally invasive procedures, rising geriatric individuals, Increasing prevalence of cardiovascular and neurovascular diseases, and increasing sedentary lifestyles and eating habits are increasing cardiac arrest cases, thereby increasing the minimally invasive procedures in hospitals. Table of Contents1 INTRODUCTION 241.1 STUDY OBJECTIVES 24 1.2 MARKET DEFINITION 24 1.2.1 INCLUSIONS AND EXCLUSIONS 24 1.3 MARKET SCOPE 25 1.3.1 MARKETS COVERED 25 FIGURE 1 MICROCATHETERS MARKET, BY SEGMENTATION 25 FIGURE 2 MICROCATHETERS MARKET, BY REGION 25 1.3.2 YEARS CONSIDERED 26 1.4 CURRENCY CONSIDERED 26 1.5 STAKEHOLDERS 26 1.6 SUMMARY OF CHANGES 27 2 RESEARCH METHODOLOGY 28 2.1 RESEARCH DATA 28 2.2 RESEARCH DESIGN 28 FIGURE 3 MICROCATHETERS MARKET: RESEARCH DESIGN 28 2.2.1 SECONDARY DATA 29 2.2.2 PRIMARY DATA 29 FIGURE 4 PRIMARY SOURCES 29 2.2.2.1 Key data from primary sources 30 2.2.2.2 Insights from primary experts 30 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 31 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 31 2.3 MARKET SIZE ESTIMATION 31 FIGURE 7 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 32 FIGURE 8 TOP-DOWN APPROACH 33 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 35 FIGURE 9 DATA TRIANGULATION METHODOLOGY 35 2.5 MARKET SHARE ESTIMATION 35 2.6 RESEARCH ASSUMPTIONS 36 2.7 STUDY LIMITATIONS 36 2.7.1 METHODOLOGY-RELATED LIMITATIONS 36 2.8 RISK ASSESSMENT 36 TABLE 1 LIMITATIONS AND ASSOCIATED RISKS 36 3 EXECUTIVE SUMMARY 37 FIGURE 10 MICROCATHETERS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 37 FIGURE 11 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2022 VS. 2027 (USD MILLION) 38 FIGURE 12 MICROCATHETERS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 38 FIGURE 13 MICROCATHETERS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 39 FIGURE 14 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 39 4 PREMIUM INSIGHTS 41 4.1 MICROCATHETERS MARKET OVERVIEW 41 FIGURE 15 TECHNOLOGICAL ADVANCEMENTS AND RISING CHRONIC DISEASE INCIDENCE TO DRIVE DEMAND 41 4.2 MICROCATHETERS MARKET SHARE, BY COUNTRY AND PRODUCT 42 FIGURE 16 NORTH AMERICA TO HOLD LARGEST SHARE OF GLOBAL MARKET 42 4.3 MICROCATHETERS MARKET SHARE, BY END USER 42 FIGURE 17 HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 42 4.4 GEOGRAPHICAL SNAPSHOT OF MICROCATHETERS MARKET 43 FIGURE 18 INDIA TO GROW AT HIGHEST RATE DURING 2022–2027 43 5 MARKET OVERVIEW 44 5.1 INTRODUCTION 44 5.2 MARKET DYNAMICS 44 FIGURE 19 MICROCATHETERS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 44 5.2.1 DRIVERS 45 5.2.1.1 Technological advancements in interventional cardiology 45 5.2.1.2 Expansion of patient population suffering from chronic illness 45 5.2.1.3 Increasing conferences and symposia to spread awareness about benefits of microcatheters 45 5.2.2 RESTRAINTS 46 5.2.2.1 Stringent regulatory guidelines and high cost of drug approval 46 5.2.2.2 Lack of awareness about microcatheters in underdeveloped or emerging countries 46 5.2.3 OPPORTUNITIES 46 5.2.3.1 Rising number of patients suffering from chronic diseases and cancer globally 46 5.3 KEY STAKEHOLDERS AND BUYING CRITERIA 47 5.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 47 FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROCATHETERS MARKET 47 TABLE 2 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR MICROCATHETERS MARKET 47 5.4 PORTER’S FIVE FORCES ANALYSIS 47 5.4.1 OVERVIEW 47 TABLE 3 MICROCATHETERS MARKET: PORTER’S FIVE FORCES ANALYSIS 48 5.4.2 THREAT OF NEW ENTRANTS 48 5.4.3 THREAT OF SUBSTITUTES 48 5.4.4 BARGAINING POWER OF SUPPLIERS 48 5.4.5 BARGAINING POWER OF BUYERS 48 5.4.6 DEGREE OF COMPETITION 49 5.5 REGULATORY ANALYSIS 49 5.5.1 US 49 TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 50 5.5.2 EUROPE 50 5.5.3 JAPAN 50 TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 51 5.6 REIMBURSEMENT ANALYSIS 51 TABLE 6 CPT CODES FOR MAJOR MICROCATHETERS 51 5.7 ECOSYSTEM ANALYSIS 52 5.8 VALUE CHAIN ANALYSIS 53 5.8.1 RESEARCH AND DEVELOPMENT 53 5.8.2 PROCUREMENT AND PRODUCT DEVELOPMENT 53 5.8.3 MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES 53 FIGURE 21 VALUE CHAIN ANALYSIS 53 5.9 SUPPLY CHAIN ANALYSIS 54 5.9.1 PROMINENT COMPANIES 54 5.9.2 SMALL & MEDIUM-SIZED COMPANIES 54 5.9.3 END USERS 54 FIGURE 22 SUPPLY CHAIN ANALYSIS 54 5.10 PATENT ANALYSIS 54 5.11 TRADE ANALYSIS 55 TABLE 7 IMPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2020–2022 (USD MILLION) 55 TABLE 8 EXPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2020–2022 (USD MILLION) 55 5.12 KEY CONFERENCES AND EVENTS IN 2022–2023 56 TABLE 9 MICROCATHETERS MARKET: DETAILED LIST OF MAJOR CONFERENCES AND EVENTS 56 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 56 FIGURE 23 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX 57 6 MICROCATHETER MARKET, BY PRODUCT 58 6.1 INTRODUCTION 59 TABLE 10 MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 59 TABLE 11 MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 59 TABLE 12 MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 60 TABLE 13 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 60 6.2 DELIVERY MICROCATHETERS 60 6.2.1 INCREASED NUMBER OF TARGET INTERVENTIONAL PROCEDURES TO DRIVE MARKET 60 TABLE 14 DELIVERY MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 61 TABLE 15 DELIVERY MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 61 TABLE 16 DELIVERY MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 62 TABLE 17 DELIVERY MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 62 6.3 ASPIRATION MICROCATHETERS 63 6.3.1 INCREASING BURDEN OF CARDIOVASCULAR DISEASES AND RELATED MEDICAL PROCEDURES TO AUGMENT MARKET 63 TABLE 18 ASPIRATION MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 63 TABLE 19 ASPIRATION MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 63 TABLE 20 ASPIRATION MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 64 TABLE 21 ASPIRATION MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 64 6.4 DIAGNOSTICS MICROCATHETERS 65 6.4.1 LARGE PATIENT POPULATION FOR VASCULAR DISEASES TO AID MARKET 65 TABLE 22 DIAGNOSTIC MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 65 TABLE 23 DIAGNOSTIC MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 65 TABLE 24 DIAGNOSTIC MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 66 TABLE 25 DIAGNOSTIC MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 66 6.5 STEERABLE MICROCATHETERS 67 6.5.1 GROWING NUMBER OF IMAGE-GUIDED AND MINIMALLY INVASIVE MEDICAL PROCEDURES TO BOOST MARKET 67 TABLE 26 STEERABLE MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 67 TABLE 27 STEERABLE MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 67 TABLE 28 STEERABLE MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 68 TABLE 29 STEERABLE MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 68 7 MICROCATHETERS MARKET, BY PRODUCT DESIGN 69 7.1 INTRODUCTION 70 TABLE 30 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 70 7.2 SINGLE LUMEN MICROCATHETERS 70 7.2.1 INCREASING NUMBER OF TARGET MEDICAL PROCEDURES AND OPERATIONAL ADVANTAGES TO PROPEL MARKET 70 TABLE 31 SINGLE LUMEN MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 71 7.3 DUAL-LUMEN MICROCATHETERS 71 7.3.1 PRODUCT ADVANTAGES AND INCREASED ADOPTION OF CATHETERS TO DRIVE MARKET 71 TABLE 32 DUAL-LUMEN MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 72 8 MICROCATHETERS MARKET, BY APPLICATION 73 8.1 INTRODUCTION 74 TABLE 33 MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 74 8.2 CARDIOVASCULAR APPLICATIONS 74 8.2.1 PROCEDURAL BENEFITS DURING CRITICAL CARDIAC SURGERIES TO AID MARKET 74 TABLE 34 MICROCATHETERS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 75 8.3 NEUROVASCULAR APPLICATIONS 75 8.3.1 INCREASING INCIDENCE OF TARGET NEUROLOGICAL CONDITIONS TO DRIVE MARKET 75 TABLE 35 MICROCATHETERS MARKET FOR NEUROVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 76 8.4 PERIPHERAL VASCULAR APPLICATION 76 8.4.1 RISING TARGET DIAGNOSTIC AND INTERVENTIONAL PROCEDURES TO STIMULATE MARKET 76 TABLE 36 MICROCATHETERS MARKET FOR PERIPHERAL VASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 77 8.5 ONCOLOGY APPLICATIONS 77 8.5.1 INCREASING CLINICAL RESEARCH ON MINIMALLY INVASIVE CANCER TREATMENT TO DRIVE MARKET 77 TABLE 37 MICROCATHETERS MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 78 9 MICROCATHETERS MARKET, BY END USER 79 9.1 INTRODUCTION 80 TABLE 38 MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 80 9.2 HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS 80 9.2.1 LARGE NUMBER OF SURGICAL AND DIAGNOSTIC PROCEDURES TO PROPEL MARKET 80 TABLE 39 MICROCATHETERS MARKET FOR HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS, BY REGION, 2020–2027 (USD MILLION) 81 9.3 AMBULATORY CARE CENTERS 81 9.3.1 LIMITED SURGICAL CAPABILITIES OF AVAILABLE PRODUCTS TO RESTRAIN ADOPTION 81 TABLE 40 MICROCATHETERS MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2020–2027 (USD MILLION) 82 10 MICROCATHETERS MARKET, BY REGION 83 10.1 INTRODUCTION 84 TABLE 41 MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 84 10.2 NORTH AMERICA 85 FIGURE 24 NORTH AMERICA: MARKET SNAPSHOT 85 TABLE 42 NORTH AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85 TABLE 43 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 86 TABLE 44 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 86 TABLE 45 NORTH AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 87 TABLE 46 NORTH AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 87 10.2.1 US 88 10.2.1.1 US to dominate North American market during forecast period 88 TABLE 47 US: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 88 10.2.2 CANADA 88 10.2.2.1 Increasing prevalence of target diseases and high demand for timely diagnosis to propel market 88 TABLE 48 CANADA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 89 10.3 EUROPE 89 TABLE 49 EUROPE: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89 TABLE 50 EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 90 TABLE 51 EUROPE: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 90 TABLE 52 EUROPE: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 90 TABLE 53 EUROPE: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 91 10.3.1 GERMANY 91 10.3.1.1 Increasing aging population and rising life expectancy to boost market 91 TABLE 54 GERMANY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 91 10.3.2 FRANCE 92 10.3.2.1 Significant evolution of healthcare sector to drive market 92 TABLE 55 FRANCE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 92 10.3.3 UK 92 10.3.3.1 High burden of chronic diseases and large volume of surgeries to augment market 92 TABLE 56 UK: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 93 10.3.4 ITALY 93 10.3.4.1 Increasing geriatric population to aid growth 93 TABLE 57 ITALY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 93 10.3.5 SPAIN 93 10.3.5.1 Increasing technological developments in healthcare sector to propel market 93 TABLE 58 SPAIN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 94 10.3.6 REST OF EUROPE 94 TABLE 59 REST OF EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 94 10.4 ASIA PACIFIC 95 FIGURE 25 ASIA PACIFIC: MARKET SNAPSHOT 95 TABLE 60 ASIA PACIFIC: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96 TABLE 61 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 96 TABLE 62 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 96 TABLE 63 ASIA PACIFIC: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 97 TABLE 64 ASIA PACIFIC: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 97 10.4.1 JAPAN 98 10.4.1.1 Increasing geriatric population and surgical procedures to drive market 98 TABLE 65 JAPAN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 98 10.4.2 CHINA 99 10.4.2.1 Growing prevalence of chronic disorders and developing healthcare infrastructure to aid growth 99 TABLE 66 CHINA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 99 10.4.3 INDIA 100 10.4.3.1 Increasing target patient population with rising availability of advanced surgical treatments to drive market 100 TABLE 67 INDIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 100 10.4.4 AUSTRALIA 100 10.4.4.1 Developing healthcare sector and increasing availability of advanced surgical treatments to stimulate market 100 TABLE 68 AUSTRALIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 101 10.4.5 SOUTH KOREA 101 10.4.5.1 Growing target patient population for cardiovascular diseases to drive market 101 TABLE 69 SOUTH KOREA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 101 10.4.6 REST OF ASIA PACIFIC 102 TABLE 70 REST OF ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 102 10.5 LATIN AMERICA 102 10.5.1 FAVORABLE ECOSYSTEM FOR MEDICAL EQUIPMENT AND SUPPLIES TO DRIVE MARKET 102 TABLE 71 LATIN AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 103 TABLE 72 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 103 TABLE 73 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 103 TABLE 74 LATIN AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 104 TABLE 75 LATIN AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 104 10.6 MIDDLE EAST & AFRICA 105 10.6.1 INCREASING FOCUS OF MARKET PLAYERS TO ESTABLISH THEIR PRESENCE TO PROPEL MARKET 105 TABLE 76 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 105 TABLE 77 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 106 TABLE 78 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 106 TABLE 79 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 106 11 COMPETITIVE LANDSCAPE 107 11.1 OVERVIEW 107 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 107 FIGURE 26 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MICROCATHETERS MARKET 108 11.3 MARKET RANKING ANALYSIS 109 FIGURE 27 MICROCATHETERS MARKET (2021) 109 11.3.1 BOSTON SCIENTIFIC CORPORATION 109 11.3.2 ASAHI INTECC CO., LTD. 110 11.3.3 MEDTRONIC PLC 110 11.3.4 TELEFLEX 110 11.3.5 TERUMO MEDICAL CORPORATION 111 11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 111 FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN MICROCATHETERS MARKET 111 11.5 COMPETITIVE BENCHMARKING OF TOP 26 PLAYERS 112 TABLE 80 OVERALL FOOTPRINT OF COMPANIES 112 TABLE 81 PRODUCT FOOTPRINT OF COMPANIES (26 COMPANIES) 113 TABLE 82 END USER FOOTPRINT OF COMPANIES (26 COMPANIES) 114 TABLE 83 REGIONAL FOOTPRINT OF COMPANIES (26 COMPANIES) 115 11.6 COMPANY EVALUATION QUADRANT 116 11.6.1 STARS 117 11.6.2 EMERGING LEADERS 117 11.6.3 PERVASIVE PLAYERS 117 11.6.4 PARTICIPANTS 117 FIGURE 29 MICROCATHETERS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021) 118 11.7 START-UPS/SMES EVALUATION QUADRANT 118 11.7.1 PROGRESSIVE COMPANIES 118 11.7.2 DYNAMIC COMPANIES 118 11.7.3 STARTING BLOCKS 119 11.7.4 RESPONSIVE COMPANIES 119 FIGURE 30 MICROCATHETERS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2021) 119 11.8 COMPETITIVE SCENARIO 120 11.8.1 PRODUCT LAUNCHES AND APPROVALS 120 TABLE 84 PRODUCT LAUNCHES AND APPROVALS, 2019–2022 120 11.8.2 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 121 TABLE 85 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2019–2022 121 12 COMPANY PROFILES 122 (Business Overview, Products/Services/Solutions offered, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats)* 12.1 KEY PLAYERS 122 12.1.1 BOSTON SCIENTIFIC CORPORATION 122 TABLE 86 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 122 FIGURE 31 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2021) 123 12.1.2 ASAHI INTECC CO., LTD. 125 TABLE 87 ASAHI INTECC CO., LTD: COMPANY OVERVIEW 125 FIGURE 32 ASAHI INTECC CO., LTD.: COMPANY SNAPSHOT (2021) 125 12.1.3 MEDTRONIC PLC 127 TABLE 88 MEDTRONIC PLC: COMPANY OVERVIEW 127 FIGURE 33 MEDTRONIC PLC.: COMPANY SNAPSHOT (2021) 128 12.1.4 STRYKER 130 TABLE 89 STRYKER: COMPANY OVERVIEW 130 FIGURE 34 STRYKER: COMPANY SNAPSHOT (2021) 131 12.1.5 BECTON, DICKINSON AND COMPANY 133 TABLE 90 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 133 FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021) 134 12.1.6 TERUMO MEDICAL CORPORATION 136 TABLE 91 TERUMO MEDICAL CORPORATION: COMPANY OVERVIEW 136 FIGURE 36 TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT (2021) 137 12.1.7 MERIT MEDICAL SYSTEMS, INC. 139 TABLE 92 MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW 139 FIGURE 37 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2021) 140 12.1.8 CARDINAL HEALTH 142 TABLE 93 CARDINAL HEALTH: COMPANY OVERVIEW 142 FIGURE 38 CARDINAL HEALTH: COMPANY SNAPSHOT (2021) 143 12.1.9 B. BRAUN MELSUNGEN AG 145 TABLE 94 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 145 12.1.10 COOK MEDICAL GROUP 147 TABLE 95 COOK MEDICAL GROUP: COMPANY OVERVIEW 147 12.1.11 TELEFLEX 150 TABLE 96 TELEFLEX: COMPANY OVERVIEW 150 12.1.12 JOHNSON & JOHNSON 151 TABLE 97 JOHNSON & JOHNSON: COMPANY OVERVIEW 151 12.1.13 ANGIODYNAMICS 152 TABLE 98 ANGIODYNAMICS: COMPANY OVERVIEW 152 12.1.14 PENUMBRA 153 TABLE 99 PENUMBRA: COMPANY OVERVIEW 153 12.1.15 BTG PLC 154 TABLE 100 BTG PLC: COMPANY OVERVIEW 154 12.1.16 GUERBET LLC 155 TABLE 101 GUERBET LLC: COMPANY OVERVIEW 155 12.1.17 EMBOLX INC. 156 TABLE 102 EMBOLX INC.: COMPANY OVERVIEW 156 12.1.18 TOKAI MEDICAL 157 TABLE 103 TOKAI MEDICAL: COMPANY OVERVIEW 157 12.1.19 KANEKA CORPORATION 158 TABLE 104 KANEKA CORPORATION.: COMPANY SNAPSHOT 158 12.1.20 INTEGER HOLDINGS CORPORATION 159 TABLE 105 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW 159 12.1.21 LIBATAPE PHARMACEUTICAL CO., LTD. 159 TABLE 106 LIBATAPE PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW 159 12.1.22 MICROVENTION TERUMO 160 TABLE 107 MICROVENTION TERUMO: COMPANY OVERVIEW 160 12.1.23 REFLOW MEDICAL 160 TABLE 108 REFLOW MEDICAL: COMPANY OVERVIEW 160 12.1.24 SPARTAN MICRO 161 TABLE 109 SPARTAN MICRO: COMPANY OVERVIEW 161 12.1.25 TRANSIT SCIENTIFIC 161 TABLE 110 TRANSIT SCIENTIFIC: COMPANY OVERVIEW 161 12.1.26 TRISALUS LIFE SCIENCES, INC. 162 TABLE 111 TRISALUS LIFE SCIENCES, INC.: COMPANY OVERVIEW 162 *Details on Business Overview, Products Offered, Recent Developments, Deals, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats might not be captured in case of unlisted companies. 13 APPENDIX 163 13.1 DISCUSSION GUIDE 163 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 166 13.3 CUSTOMIZATION OPTIONS 168 13.4 RELATED REPORTS 168 13.5 AUTHOR DETAILS 169
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(一般医療機器)の最新刊レポート
MarketsandMarkets社の一般医療機器分野での最新刊レポート
本レポートと同じKEY WORD(ambulatory surgical)の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |